Cerity Partners
AXSM icon

Cerity Partners’s Axsome Therapeutics AXSM Stock Holding History

Cerity Partners’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Buy
5,627
+242
+4% +$52.5K ﹤0.01% 1794
2026
Q1 		$910K Sell
5,385
-4
-0.1% -$691 ﹤0.01% 1913
2025
Q4 		$984K Sell
5,389
-15
-0.3% -$2.09K ﹤0.01% 1735
2025
Q3 		$656K Sell
5,404
-248
-4% -$27.9K ﹤0.01% 1820
2025
Q2 		$590K Sell
5,652
-55
-1% -$5.82K ﹤0.01% 1777
2025
Q1 		$666K Buy
5,707
+766
+16% +$87.3K ﹤0.01% 1617
2024
Q4 		$419K Buy
4,941
+1,198
+32% +$110K ﹤0.01% 1865
2024
Q3 		$336K Buy
+3,743
New +$327K ﹤0.01% 1984

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cerity Partners's AXSM Position: Q2 2026 in Review

Cerity Partners increased its Axsome Therapeutics (AXSM) stake by 4.5% in Q2 2026, buying an estimated $52.5K and bringing the position to 5,627 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1794.

Cerity Partners first reported a position in AXSM in Q3 2024 and has held it in 8 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Cerity Partners held 5,627 shares of Axsome Therapeutics worth $1.38M as of Q2 2026.
  • Cerity Partners bought 242 Axsome Therapeutics shares in Q2 2026, an estimated $52.5K.
  • Axsome Therapeutics made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1794 holding.
  • Cerity Partners first reported a position in Axsome Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.